TY - BOOK AU - Laurence, B. AU - Bruce, C. AU - Bjorn, K. PY - 2011 DA - 2011// TI - Goodman and Gilman’s pharmacological basis of therapeutics PB - Mc Graw Hill CY - New York ID - Laurence2011 ER - TY - STD TI - Mylan Pharmaceuticals. Product information for hydrochlorothiazide tablets, USP 12.5 mg, 25 mg and 50 mg. Revised in May 2011. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/040735s004,040770s003lbl.pdf. Accessed 8 July 2017. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/040735s004,040770s003lbl.pdf ID - ref2 ER - TY - JOUR AU - Cianfrone, G. AU - Pentangelo, D. AU - Cianfrone, F. PY - 2011 DA - 2011// TI - Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide JO - Eur Rev Med Pharmacol Sci VL - 15 ID - Cianfrone2011 ER - TY - STD TI - Electronic Medicines Compendium (eMC). Summary of Product Characteristics of hydrochlorothiazide 25 mg and amiloride hydrochloride tablet. URL: https://www.medicines.org.uk/EMC/medicine/17997/SPC/Moduret+25/. Accessed 20 Aug 2017. UR - https://www.medicines.org.uk/EMC/medicine/17997/SPC/Moduret+25/ ID - ref4 ER - TY - STD TI - Medicines and Health Products Regulation. Summary of Product Characteristics of hydrochlorothiazide 25 mg tablet. Available at: http://www.mhra.gov.uk/spc-pil/?subsName=HYDROCHLOROTHIAZIDE&pageID=SecondLevel. Accessed 20 Aug 2017. UR - http://www.mhra.gov.uk/spc-pil/?subsName=HYDROCHLOROTHIAZIDE&pageID=SecondLevel ID - ref5 ER - TY - STD TI - United States Food and Drug Administration. Hydrochlorothiazide prescribing information. Available at: www.drugs.com/sfx/hydrochlorothiazide-side-effects.html. Accessed on 23 Oct 2017. UR - http://www.drugs.com/sfx/hydrochlorothiazide-side-effects.html ID - ref6 ER - TY - STD TI - QUALITEST PHARMACEUTICALS. Product information for hydrochlorothiazide tablets. URL: https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=69458. Revised December 2011. Accessed 31 Jan 2017. UR - https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=69458 ID - ref7 ER - TY - JOUR AU - Palomar Garcia, V. AU - Abdulghani Martinez, F. AU - Bodet Agusti, E. AU - Andreu Mencia, L. AU - Palomar Asenjo, V. PY - 2001 DA - 2001// TI - Drug induced ototoxicity: current status JO - Acta Otolaryngol VL - 121 UR - https://doi.org/10.1080/00016480121545 DO - 10.1080/00016480121545 ID - Palomar Garcia2001 ER - TY - JOUR AU - Mick, P. AU - Westerberg, B. D. PY - 2007 DA - 2007// TI - Sensorineural hearing loss as a probable serious adverse drug reaction associated with low-dose oral azithromycin JO - J Otolaryngol VL - 36 UR - https://doi.org/10.2310/7070.2007.0047 DO - 10.2310/7070.2007.0047 ID - Mick2007 ER - TY - STD TI - Veda. http://vestibular.org/ototoxicity. Accessed 8 July 2017. UR - http://vestibular.org/ototoxicity ID - ref10 ER - TY - STD TI - Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315–21. https://doi.org/10.1007/s002280050466 ID - ref11 ER - TY - STD TI - Norén GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22:57–69. https://doi.org/10.1177/0962280211403604 ID - ref12 ER - TY - JOUR AU - Shakir, S. A. AU - Layton, D. PY - 2002 DA - 2002// TI - Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford–Hill criteria JO - Drug Saf VL - 25 UR - https://doi.org/10.2165/00002018-200225060-00012 DO - 10.2165/00002018-200225060-00012 ID - Shakir2002 ER - TY - JOUR AU - Naranjo, C. A. AU - Busto, U. AU - Sellers, E. M. PY - 1981 DA - 1981// TI - A method for estimatingthe probability of adverse drug reactions JO - Clin Pharmacol Ther VL - 30 UR - https://doi.org/10.1038/clpt.1981.154 DO - 10.1038/clpt.1981.154 ID - Naranjo1981 ER - TY - STD TI - Brummett RE. Drug-induced Ototoxicity. Drugs. 1980;19(6):412–28. URL: https://doi.org/10.2165/00003495-198019060-00002 ID - ref15 ER - TY - JOUR AU - Sheppard, A. AU - Hayes, S. H. AU - Chen, G. D. AU - Ralli, M. AU - Salvi, R. PY - 2014 DA - 2014// TI - Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology JO - Acta Otorhinolaryngol Ital VL - 34 ID - Sheppard2014 ER - TY - JOUR AU - Van Eyken, E. AU - Van Camp, G. AU - Van Laer, L. PY - 2007 DA - 2007// TI - The complexity of age-related hearing impairment: Contributing environmental and genetic factors JO - Audiol Neurootol VL - 12 UR - https://doi.org/10.1159/000106478 DO - 10.1159/000106478 ID - Van Eyken2007 ER - TY - JOUR AU - Mondelli, M. F. C. G. AU - Lopes, A. C. PY - 2009 DA - 2009// TI - Relation between arterial hypertension and hearing loss JO - Intl Arch Otorhinolaryngol VL - 13 ID - Mondelli2009 ER - TY - JOUR AU - Fausti, S. A. AU - Frey, R. H. PY - 1992 DA - 1992// TI - Portable stimulus generator for obtaining high-frequency (8-14 Khz) auditory brainstem responses JO - J Am Acad Audiol VL - 3 ID - Fausti1992 ER -